Accelerating COVID-19 Clinical Recovery in the Outpatient Setting: Retrospective Analysis

NCT05520944 · clinicaltrials.gov ↗

UNKNOWN

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
COVID-19 Pandemic
COVID-19 Respiratory Infection
SARS CoV 2 Infection
SARS-CoV-2 Acute Respiratory Disease

Interventions

DRUG: ClorNovir® (Chlorpheniramine) 0.4% Nasal Spray

Sponsor

Dr. Ferrer BioPharma

Collaborators

[object Object]